APHIS takes comments to Jan. 11 on Mozza Foods' MF1786-1 soybean, engineered to grow cow's milk casein in the seed
USDA's draft risk assessment finds the soybean no more of a plant pest than conventional beans. If APHIS agrees, keeping a milk-protein crop out of the commodity soybean stream falls to the company, not the agency.
Four grams of casein for every 100 grams of soybeans: that is what Mozza Foods says its engineered beans produce today, with 7 grams as its target[5]. On November 12 the Animal and Plant Health Inspection Service (APHIS) opened a 60-day comment period on the company’s petition to deregulate the soybean, MF1786-1, and on a draft risk assessment that finds it unlikely to pose more plant pest risk than the soybean it came from[1]. Comments are due January 11, 2027[1].
The decision matters to two groups of readers at once. Soybean growers and elevators would be handling a crop that carries a cow’s milk protein. Dairy producers would be watching a plant-grown version of the protein that makes cheese stretch.
What APHIS published
The notice, in Docket APHIS-2026-0562, covers APHIS Petition Number 25-239-01p[1]. Mozza asks for a determination of nonregulated status under 7 CFR part 340, the rules APHIS writes under the plant pest provisions of the Plant Protection Act to oversee genetically engineered organisms that are, or may be, plant pests[1].
According to the notice, MF1786-1 was engineered to do three things in the seed[1]:
- Express three bovine caseins: alpha S1, beta and kappa
- Express the FAM20C kinase, an enzyme, alongside them
- Reduce soybean glycinin proteins
The soybean also carries glufosinate resistance, which the notice describes only as a selectable marker to help identify transformed plants[1]. The petition, as APHIS summarizes it, does not present that marker as a herbicide-tolerance trait for growers.
APHIS’s draft plant pest risk assessment compared MF1786-1 with the nonmodified variety it was derived from and concluded it “is unlikely to pose an increased plant pest risk compared to the nonmodified soybean”[1]. The agency says it is “particularly interested” in comments on biological or ecological issues and encourages commenters to send data and studies[1]. After the comment period, APHIS will approve or deny the petition, post its determination on its website and publish a notice in the Federal Register[1].
The notice was signed November 5 by APHIS Administrator Kelly Moore[1].
How narrow is USDA’s review of a casein soybean?
Narrower than many readers may assume. APHIS resumed accepting petitions for nonregulated status on March 3, 2025, and developers must show the modified plant is unlikely to pose greater plant pest risk than the unmodified plant[7]. Then, in July 2025, APHIS said it would no longer prepare a National Environmental Policy Act analysis alongside these petitions[2]. If the agency finds an engineered organism is not a plant pest, it ends its review[2].
The July 2025 announcement goes further, and this is the part that bears on a milk-protein crop. Once APHIS makes that finding, the agency wrote, it “has neither discretion to regulate the modified organism nor to impose any conditions on it” under part 340[2]. It also said it has no ability under the plant pest provisions to consider or mitigate environmental impacts after that point[2].
In practice, APHIS’s question is whether MF1786-1 behaves like a weed or plant pest. Whether casein beans end up in the wrong grain bin is not part of that question. The same process applied to Pioneer’s COR121 corn, covered in earlier coverage.
In the field: a crop that has to stay out of the commodity bin
For soybean growers, MF1786-1 would be a contract crop, not something sold at the local elevator. Mozza Foods CEO Adam Tarshis told AgFunderNews in May that scaling depends mainly on getting more seed to farmers and adding acreage[5]. The company said it had run three years of field trials across several states, and described itself as being in the crop-segregation business as much as the seed business[5]. It has built an identity-preservation system it calls Grain Track to trace beans from the field to the end customer[5].
Why segregation carries weight here: milk and soybeans both sit on the federal list of nine major food allergens[4]. FDA inspects food facilities for allergen cross-contact, which it defines as the inadvertent introduction of a major food allergen into a product, and works with firms on recalls when it finds undeclared allergens[4]. A casein soybean mixed into a commodity soybean lot would put a milk protein where buyers expect only soy.
The companies in this field have said as much themselves. Alpine Bio, a different startup growing casein in soybeans, harvested what AgFunderNews described in November 2024 as its first large-scale crop, in Nebraska[6]. That report said Alpine uses GPS tracking during planting and harvest and was testing geofencing on trucks and visual markers to make its seed look different[6]. Alpine also acknowledged that its soy protein stream may carry small amounts of dairy, and its casein stream small amounts of soy[6]. AgFunderNews noted that FDA had recently warned molecular farming companies about allergen risks, without describing the warning’s terms[6].
Mozza’s plan for the rest of the bean, as reported, is conventional. Soybean oil is refined free of casein, the company said, and the soy protein fraction can go into animal feed[5]. Separation would run on standard dairy filtration equipment, because the soybeans make casein micelles large enough to filter out[5].
For dairy producers, MF1786-1 is a potential competitor for ingredient casein, though not yet a commercial one. Tarshis told AgFunderNews the company sells business to business and that dairy buyers care most about price parity and reliable supply[5]. Mozza targets a launch of its first dairy proteins in late 2028 and says it has relationships with major U.S. and European dairy manufacturers[5]. It has raised about $24 million and was raising a $4 million Series A extension as of May[5]. The record this piece draws on contains no statement from dairy producer groups on the petition.
In Washington: USDA decides on the plant, FDA on the protein
An APHIS decision clears only the growing side. In May, Mozza said it was counting on USDA approval to grow the soybean and FDA approval to sell the casein, and that it planned a generally recognized as safe (GRAS) submission to FDA in mid-2027[5].
The FDA rules on that step are in flux. Under current regulations, a company that concludes a food substance is GRAS may notify FDA but is not required to; the notice is voluntary[3]. FDA proposed on August 11, 2026, to make GRAS notices mandatory for certain uses of substances in human and animal food, in Docket FDA-2025-N-3262[3]. The agency said the change would give it and the public more information on substances in the food supply and help it identify potentially unsafe ones[3]. The proposal also includes a time-limited option for streamlined submissions on substances already marketed before a final rule takes effect[3].
That proposal could matter to the soy protein co-product as well as the casein. The FDA rule covers both human and animal food substances[3], and Mozza has said its soy protein fraction could go to feed[5].
What to watch
- December 9, 2026: Comments close on FDA’s mandatory GRAS notice proposal[3].
- January 11, 2027: Comments close on the MF1786-1 petition and draft risk assessment[1].
- After that: APHIS approves or denies the petition and publishes its determination in the Federal Register[1]. No deadline for that decision appears in the notice[1].
- Mid-2027: Mozza’s planned GRAS submission to FDA, by the company’s account[5].
Whether FDA’s GRAS rule is final by the time Mozza files, and what segregation standard buyers of commodity soybeans will expect from casein-bean growers, are both open. Neither agency’s notice answers the second question.